Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasonographic Assessment of Treatment-Induced Echogenicity Changes in Masticatory and Cervical Muscles in Patients With Myofascial Pain
NCT07676799Completed
- Sponsor
- Medipol Mega University Hospital
- Start
- May 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in myofascial pain syndrome (MPS) (3 arms), sponsored by Medipol Mega University Hospital. Primary endpoints: Change in pain score at 3 months and Internal Structure of muscles at 3 months. Started May 2026; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07676799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07676799.